Insider · CIK 0001824252

Zeng Ling

Reports to the SEC for 2 companies · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001824252

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-02-07	Omega Therapeutics, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+125K sh	—	—	125,000
2023-02-28	Omega Therapeutics, Inc.Option (Right to Buy)A Award	See Remarks	AAward	+55K sh	—	—	55,000
2022-10-27	Omega Therapeutics, Inc.Option (Right to Buy)A Award	See Remarks	AAward	+55K sh	—	—	55,000
2022-03-31	Omega Therapeutics, Inc.Option (Right to Buy)A Award	See Remarks	AAward	+270K sh	—	—	270,000
2021-12-28	Dicerna Pharmaceuticals IncU Disposition from Tender	Chief Legal Officer & Sec'y	UDisposition from Tender	−5,032 sh	$38.25	−$192K	0
2021-12-28	Dicerna Pharmaceuticals IncRestricted Stock UnitsD Disposition to Issuer	Chief Legal Officer & Sec'y	DDisposition to Issuer	−7,688 sh	—	—	0
2021-12-28	Dicerna Pharmaceuticals IncRestricted Stock UnitsD Disposition to Issuer	Chief Legal Officer & Sec'y	DDisposition to Issuer	−13.7K sh	—	—	0
2021-12-28	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Chief Legal Officer & Sec'y	DDisposition to Issuer	−81.8K sh	—	—	0
2021-12-28	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Chief Legal Officer & Sec'y	DDisposition to Issuer	−46.1K sh	—	—	0
2021-12-15	Dicerna Pharmaceuticals IncM Exercise/Conversion	Chief Legal Officer & Sec'y	MExercise/Conversion	+2,562 sh	—	—	5,784
2021-12-15	Dicerna Pharmaceuticals IncF Tax Payment	Chief Legal Officer & Sec'y	FTax Payment	−752 sh	$38.05	−$28.6K	5,032
2021-12-15	Dicerna Pharmaceuticals IncRestricted Stock UnitsM Exercise/Conversion	Chief Legal Officer & Sec'y	MExercise/Conversion	−2,562 sh	—	—	7,688
2021-09-17	Dicerna Pharmaceuticals IncS Sale	Chief Legal Officer & Sec'y	SSale	−1,334 sh	$21.47	−$28.6K	3,222
2021-09-15	Dicerna Pharmaceuticals IncM Exercise/Conversion	Chief Legal Officer & Sec'y	MExercise/Conversion	+4,556 sh	—	—	4,556
2021-09-15	Dicerna Pharmaceuticals IncRestricted Stock UnitsM Exercise/Conversion	Chief Legal Officer & Sec'y	MExercise/Conversion	−4,556 sh	—	—	13,669
2021-01-12	Dicerna Pharmaceuticals IncRestricted Stock UnitsA Award	Chief Legal Officer & Sec'y	AAward	+10.3K sh	—	—	10,250
2021-01-12	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)A Award	Chief Legal Officer & Sec'y	AAward	+46.1K sh	—	—	46,120
2020-10-01	Dicerna Pharmaceuticals IncRestricted Stock UnitsA Award	Chief Legal Officer & Sec'y	AAward	+18.2K sh	—	—	18,225
2020-10-01	Dicerna Pharmaceuticals IncEmployee Stock Option (Right to Buy)A Award	Chief Legal Officer & Sec'y	AAward	+81.8K sh	—	—	81,825

Recent filings

Accepted (ET)
Feb 94
Zeng Ling0000950170-24-013350
SEC(opens sec.gov)
Mar 24
Zeng Ling0000899243-23-006730
SEC(opens sec.gov)
Oct 284
Zeng Ling0000899243-22-034469
SEC(opens sec.gov)
Apr 14
Zeng Ling0000899243-22-013103
SEC(opens sec.gov)
Dec 294
Zeng Ling0001399529-21-000206
SEC(opens sec.gov)
Dec 174
Zeng Ling0001399529-21-000172
SEC(opens sec.gov)
Sep 174
Zeng Ling0001399529-21-000150
SEC(opens sec.gov)
Jan 124
Zeng Ling0001399529-21-000012
SEC(opens sec.gov)
Oct 24
Zeng Ling0001399529-20-000069
SEC(opens sec.gov)

Companies

Address

C/O DICERNA PHARMACEUTICALS, INC. 33 HAYDEN AVENUE

LEXINGTON, MA, 02421